Good evening :)
Switch to
Place Order

GlaxoSmithKline Pharmaceuticals Ltd

GLAXO
Health CarePharmaceuticals
MidcapWith a market cap of ₹27,171 cr, stock is ranked 167
Low RiskStock is 1.43x as volatile as Nifty
1,683.1079.15 (+4.93%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
MidcapWith a market cap of ₹27,171 cr, stock is ranked 167
Low RiskStock is 1.43x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
75.87
PB RatioPB Ratio
18.13
Dividend YieldDiv. Yield
1.87%
Sector PESector PE
40.14
Sector PBSector PB
5.78
Sector Div YldSctr Div Yld
0.62%

Forecast & RatingsDetailed Forecast 

57%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Company develops a range of products in pharmaceuticals, vaccines and consumer healthcare.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020212.943.283.853.350.350.450.090.36
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Shareholders meeting 
Announced OnJul 28, 2021

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 27, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on July 27, 2021. Further, the company has submitted the Exchange a copy of Srutinizers report along with voting results. | Download

Press Release 
Announced OnJul 26, 2021

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Media release: Q1 of 2021 -22". | Download

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 26, 2021, titled "Media release: Q1 of 2021 -22". | Download

Cash Dividend 
Ex. DateJul 19, 2021

Final • Div/Share: ₹ 30

See all events